| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/2162402X.2015.1048061 |
| P953 | full work available online at | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760296 |
| P932 | PMC publication ID | 4760296 |
| P698 | PubMed publication ID | 26942056 |
| P50 | author | T Shen | Q87606196 |
| P2093 | author name string | Yu Zhang | |
| Ling Zhang | |||
| Hua Liang | |||
| Jian Gao | |||
| Fengmin Lu | |||
| Lu Long | |||
| Zhaojun Duan | |||
| Jing Tu | |||
| Xiangbo Huang | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Natural killer cells in liver disease | Q27025451 | ||
| Functions of natural killer cells | Q29614300 | ||
| Hepatocellular carcinoma | Q29615841 | ||
| Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. | Q33474008 | ||
| TGF-β1 Down-Regulation of NKG2D/DAP10 and 2B4/SAP Expression on Human NK Cells Contributes to HBV Persistence | Q34205905 | ||
| Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. | Q50956366 | ||
| Isolation, purification and flow cytometric analysis of human intrahepatic lymphocytes using an improved technique | Q51556435 | ||
| Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy | Q53383343 | ||
| The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation | Q54375212 | ||
| Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection | Q57200903 | ||
| Radiofrequency Thermal Ablation for Hepatocellular Carcinoma Stimulates Autologous NK-Cell Response | Q58802772 | ||
| Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10 | Q74230064 | ||
| Dysregulation of blood lymphocyte subsets and natural killer cells in schistosomal liver cirrhosis and hepatocellular carcinoma | Q79334439 | ||
| Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas | Q81228401 | ||
| Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients | Q82112568 | ||
| Prognostic impact of anatomical resection on early and late intrahepatic recurrence in patients with hepatocellular carcinoma | Q82213679 | ||
| Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications | Q82350262 | ||
| Roles of the NKG2D immunoreceptor and its ligands | Q34267094 | ||
| IFN-γ induces aberrant CD49b⁺ NK cell recruitment through regulating CX3CL1: a novel mechanism by which IFN-γ provokes pregnancy failure | Q34662193 | ||
| TGF-β affects development and differentiation of human natural killer cell subsets | Q34735556 | ||
| Gut inflammation and indoleamine deoxygenase inhibit IL-17 production and promote cytotoxic potential in NKp44+ mucosal NK cells during SIV infection | Q35230224 | ||
| Surface NK receptors and their ligands on tumor cells | Q36490899 | ||
| Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients | Q37158244 | ||
| NKG2D ligands in tumor immunity | Q37287179 | ||
| NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoediting | Q37424326 | ||
| Effect of NKG2D ligand expression on host immune responses | Q37764003 | ||
| Natural killer cell education and tolerance | Q37789866 | ||
| NK cells are the crucial antitumor mediators when STAT3-mediated immunosuppression is blocked in hepatocellular carcinoma | Q38976140 | ||
| A Chimeric Receptor with NKG2D Specificity Enhances Natural Killer Cell Activation and Killing of Tumor Cells | Q39213516 | ||
| MiR-10b downregulates the stress-induced cell surface molecule MICB, a critical ligand for cancer cell recognition by natural killer cells | Q39292548 | ||
| Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction | Q39662490 | ||
| Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9. | Q39748355 | ||
| Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients | Q39805787 | ||
| Blockade of natural killer cell-mediated lysis by NCAM140 expressed on tumor cells | Q40172138 | ||
| Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans. | Q40324318 | ||
| Receptors for HLA class-I molecules in human natural killer cells. | Q41039762 | ||
| Chemotherapy-elicited upregulation of NKG2D and DNAM-1 ligands as a therapeutic target in multiple myeloma. | Q41909568 | ||
| A critical role for natural killer cells in dendritic cell-based anticancer immunotherapy | Q42032698 | ||
| HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma | Q42232195 | ||
| Secretory pathways generating immunosuppressive NKG2D ligands: New targets for therapeutic intervention. | Q42702237 | ||
| Arming NK cells with enhanced antitumor activity: CARs and beyond | Q42937939 | ||
| Are natural killer cells superior CAR drivers? | Q42952399 | ||
| Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. | Q44554800 | ||
| Global PROTOMAP profiling to search for biomarkers of early-recurrent hepatocellular carcinoma | Q46459992 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| hepatectomy | Q1514021 | ||
| P304 | page(s) | e1048061 | |
| P577 | publication date | 2015-07-07 | |
| P1433 | published in | OncoImmunology | Q18026500 |
| P1476 | title | Failure recovery of circulating NKG2D(+)CD56(dim)NK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence | |
| P478 | volume | 5 |
| Q100940223 | Cryo-EM structure of the highly atypical cytoplasmic ribosome of Euglena gracilis |
| Q41574368 | Dysfunctional Natural Killer Cells in the Aftermath of Cancer Surgery. |
| Q53141065 | MiR-615-5p depresses natural killer cells cytotoxicity through repressing IGF-1R in hepatocellular carcinoma patients. |
| Q38646396 | Natural killer cells in hepatocellular carcinoma: current status and perspectives for future immunotherapeutic approaches |
| Q90706071 | The Potential for Cancer Immunotherapy in Targeting Surgery-Induced Natural Killer Cell Dysfunction |
| Q64958587 | The role of natural killer cells in hepatocellular carcinoma development and treatment: A narrative review. |
Search more.